Prognostic prediction and comparison of three staging programs for patients with advanced (T2-T4) esophageal squamous carcinoma after radical resection
View abstract on PubMed
Summary
This summary is machine-generated.Log odds of positive lymph nodes (LODDS) is a superior prognostic indicator for advanced esophageal squamous cell carcinoma compared to N stage and lymph node rate. This new model aids in treatment recommendations post-surgery.
Area Of Science
- Oncology
- Surgical Oncology
- Cancer Prognostics
Background
- Lymph node staging is crucial for esophageal cancer prognosis but accuracy is debated.
- Existing systems like N stage, lymph node rate (LNR), and log odds of positive lymph nodes (LODDS) require further validation for advanced esophageal squamous cell carcinoma (ESCC).
Purpose Of The Study
- To evaluate and compare the prognostic significance of N stage, LNR, and LODDS in patients with advanced ESCC (T2-T4).
- To identify the most accurate lymph node staging system for predicting overall survival (OS) in advanced ESCC.
Main Methods
- A cohort of 319 patients with advanced ESCC was analyzed, with validation using 409 patients from the SEER database.
- Multivariate Cox regression was used to build prognostic models and assess independent risk factors.
- Model accuracy was compared using metrics like C-index, -2LLR, LRχ2, and AIC. A nomogram was developed for the best-performing model.
Main Results
- All three systems (N stage, LNR, LODDS) were identified as independent prognostic factors for advanced ESCC.
- LODDS demonstrated superior predictive accuracy, evidenced by higher C-index and LRχ2 values, and lower AIC and -2LLR compared to N stage and LNR.
- A LODDS-based nomogram showed strong calibration and promising clinical applicability via ROC curves and DCA.
Conclusions
- Log odds of positive lymph nodes (LODDS) is a highly promising prognostic indicator for advanced ESCC.
- The developed LODDS-based nomogram can potentially guide treatment recommendations and improve patient management after surgery.
Related Concept Videos
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

